JS

Jim Sullivan

Chief Executive Officer at Vanqua Bio

Greater Chicago Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $75,000,000.00

  • Target Investment:

    $4,000,000.00

Skills

Pharmaceutical Industry
Life Sciences
Biotechnology
Clinical Development
Drug Discovery
Clinical Trials
Biopharmaceuticals
Oncology
Immunology
Regulatory Affairs
Neuroscience
Biologics
Chemistry
Molecular Pharmacology

Education

Work Experience

Vanqua Bio

2019

  • Chief Executive Officer

    2019

OrbiMed

2019

  • Venture Partner

    2019

Northwestern University

2009

  • Adjunct Professor, Department of Pharmacology

    2009

AbbVie

2013 - 2018

  • Vice President Global Discovery

    2013 - 2018

Abbott

1995 - 2012

  • Vice President Global Pharmaceutical Discovery

    2008 - 2012

  • Vice President, Neuroscience Discovery

    2001 - 2008

  • Director Neuroscience Discovery

    1997 - 2000

  • Project Leader

    1995 - 1997

Abbott

1991 - 1993

  • Sr Research Scientist, Neuroscience Discovery

    1991 - 1993

Nova Pharmaceuticals

1990 - 1991

  • Research Scientist

    1990 - 1991

Northwestern University

1987 - 1990

  • Postdoctoral Fellow, Department of Neurobiology

    1987 - 1990